Ontogeny of regulatory mechanisms for β-adrenoceptor control of rat cardiac adenylyl cyclase: Targeting of G-proteins and the cyclase catalytic subunit

Journal of Molecular and Cellular Cardiology

Volumn 29, Issue 2, 1997, Pages 603-615

  Zeiders, J L ^a   Seidler, F J ^a   Slotkin, T A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenylyl cyclase; Cardiac adenylyl cyclase; Isoproterenol; adrenoceptor

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CARBACHOL; CATECHOLAMINE; FORSKOLIN; GLUCAGON; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; MEMBRANE PROTEIN; MUSCARINIC RECEPTOR; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ADRENERGIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SUBUNIT; FEMALE; HEART MUSCLE FIBER MEMBRANE; MALE; NEWBORN; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

EID: 0031079703     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0303     Document Type: Article

References (67)

1. ADOLPH EF, 1965. Capacities for regulation of heart rate in fetal, infant, and adult rats. Amer J Physiol 209: 1095-1105.
2. BALDWIN KM, CAMPBELL PJ, HOOKER AM, LEWIS RE, 1979. Effects of thyroid deficiency and sympathectomy on cardiac enzymes. Amer J Physiol 236: C30-C34.
3. BIAN X-P, SEIDLER FJ, SLOTKIN TA, 1992. Promotional role for glucocorticoids in the development of intracellular signalling: enhanced cardiac and renal adenylate cyclase reactivity to β-adrenergic and non-adrenergic stimuli after low-dose fetal dexamethasone exposure. J Dev Physiol 17: 289-297.
4. BIRK E, TYNDALL MR, ERICKSON LC, RUDOLPH AM, ROBERTS JM, 1992. Effects of thyroid hormone on myocardial adrenergic β-receptor responsiveness and function during late gestation. Pediatr Res 31: 468-473.
5. BOREUS LO, HJEMDAHL P, LAGERCRANTZ H, MARTINSSON A, YAO AC, 1986. β-Adrenoceptor function in white blood cells from newborn infants: no relation to plasma catecholamine levels. Pediatr Res 20: 1152-1155.
6. CHAUDHRY A, GRANNEMAN JG, 1991. Developmental changes in adenylyl cyclase and GTP binding proteins in brown fat. Amer J Physiol 261: R403-R411.
7. sα activity. Amer J Physiol 263: R34-R38.
8. 3 adrenergic receptors to brown fat adenylyl cyclase. J Pharmacol Exp Ther 261: 633-637.
9. CHAUDHRY A, MUFFLER LA, YAO RH, GRANNEMAN JG, 1996. Perinatal expression of adenylyl cyclase subtypes in rat brown adipose tissue. Amer J Physiol - Reg Integr Comp Physiol 39: R755-R760.
10. CLARK RB, FRIEDMAN J, DIXON RA, STRADER CD, 1989. Identification of a specific site required for rapid heterologous desensitization of the β-adrenergic receptor by cAMP-dependent protein kinase. Mol Pharmacol 36: 343-348.
11. CROS GH, CHANEZ PO, MICHEL A, BOUCARD M, SERRANO J-J, 1988. Post-natal evolution of rat cardiac beta-adrenoceptors. Life Sci 43: 699-706.
12. ESPINASSE I, IOURGENKO V, DEFER N, SAMSON F, HANOUNE J, MERCADIER JJ, 1995. Type V, but not type VI, adenylyl cyclase mRNA accumulates in the rat heart during ontogenic development: correlation with increased global adenylyl cyclase activity. J Mol Cell Cardiol 27: 1789-1795.
13. FRIEDHOFF AJ, MILLER JC, 1983. Prenatal psychotropic drug exposure and the development of central dopaminergic and cholinergic neurotransmitter systems. Monogr Neural Sci 9: 91-98.
14. GIANNUZZI CE, SEIDLER FJ, SLOTKIN TA, 1995. β-Adrenoceptor control of cardiac adenylyl cyclase during development: agonist pretreatment in the neonate uniquely causes heterologous sensitization, not desensitization. Brain Res 694: 271-278.
15. i sub-types by prolonged incubation of adipocytes with an A1 adenosine receptor agonist. J Biol Chem 265: 5206-5210.
16. HABIB DM, PADBURY JF, MARTINEZ AM, CHAPPELL BA, THIO SL, BURNELL EE, 1991. Neonatal adaptation: cardiac adrenergic effector mechanisms after birth in newborn sheep. Pediatr Res 29: 98-103.
17. iα2. J Biol Chem 265: 14784-14790.
18. HOFFMAN BB, CHANG H, DALI'AGLIO E, REAVEN GN, 1986. Desensitization of adenosine receptor-mediated inhibition of lipolysis: the mechanism involves the development of enhanced cyclic adenosine monophosphate accumulation in tolerant adipocytes. J Clin Invest 78: 185-190.
19. HOU Q-C, BAKER FE, SEIDLER FJ, BARTOLOME M, BARTOLOME J, SLOTKIN TA, 1989a. Role of sympathetic neurons in development of β-adrenergic control of ornithine decarboxylase activity in peripheral tissues: effects of neonatal 6-hydroxydopamine treatment. J Dev Physiol 11: 139-146.
20. HOU Q-C, EYLERS JP, LAPPI SE, KAVLOCK RJ, SLOTKIN TA, 1989b. Neonatal sympathectomy compromises development of responses of ornithine decarboxylase to hormonal stimulation in peripheral tissues. J Dev Physiol 12: 189-192.
21. HOU Q-C, SEIDLER FJ, SLOTKIN TA, 1989c. Development of the linkage of β-adrenergic receptors to cardiac hypertrophy and heart rate control: neonatal sympathectomy with 6-hydroxydopamine. J Dev Physiol 11: 305-311.
22. JOHNSON GL, WOLFE BB, HARDEN TK, MOLINOFF PB, PERKINS JP, 1978. Role of β-adrenergic receptors in catecholamine-induced desensitization of adenylate cyclase in human astrocytoma cells. J Biol Chem 253: 1472-1480.
23. KAWAI Y, ARINZE IJ, 1993. Glucocorticoid regulation of G-protein subunits in neonatal liver. Mol Cell Endocrinol 90: 203-209.
24. KUDLACZ EM, NAVARRO HA, KAVLOCK RJ, SLOTKIN TA, 1990a. Regulation of postnatal β-adrenergic receptor/ adenylate cyclase development by prenatal agonist stimulation and steroids: alterations in rat kidney and lung after exposure to terbutaline or dexamethasone. J Dev Physiol 14: 273-281.
25. KUDLACZ EM, NAVARRO HA, SLOTKIN TA, 1989. Phosphatidic acid phosphatase in neonatal rat lung: effects of prenatal dexamethasone or terbutaline treatment on basal activity and on responsiveness to beta adrenergic stimulation. J Pharmacol Exp Ther 250: 236-240.
26. KUDLACZ EM, NAVARRO HA, SLOTKIN TA, 1990b. Regulation of β-adrenergic receptor-mediated processes in fetal rat lung: selective desensitization caused by chronic terbutaline exposure. J Dev Physiol 14: 103-108.
27. KUDLACZ EM, SLOTKIN TA, 1990. Regulation of neonatal rat lung compliance by β-adrenergic receptor stimulation: effects of prenatal exposure to terbutaline or dexamethasone. J Dev Physiol 14: 307-310.
28. LAGERCRANTZ H, BISTOLETTI P, 1973. Catecholamine release in the newborn infant at birth. Pediatr Res 11: 889-893.
29. LAGERCRANTZ H, SLOTKIN TA, 1986. The "stress" of being born. Sci Amer 254 (April): 100-107.
30. LAU C, BURKE SP, SLOTKIN TA, 1982. Maturation of sympathetic neurotransmission in the rat heart. IX. Development of transsynaptic regulation of cardiac adrenergic sensitivity. J Pharmacol Exp Ther 223: 675-680.
31. iα are not associated with changes in the mRNAs. Mol Pharmacol 36: 681-688.
32. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL R, 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-270.
33. MAIER JA, ROBERTS JM, JACOBS MM, 1989. Ontogeny of fetal adenylate cyclase; mechanisms for regulation of β-adrenergic receptors. J Dev Physiol 12: 249-261.
34. 1-and β-adrenergic receptors. Biochem Pharmacol 36: 1-6.
35. 2+. Pharmacol Rev 40: 87-119.
36. MINNEMAN KP, PITTMAN RN, MOLINOFF PB, 1981. β-Adrenergic receptor subtypes: properties, distribution, and regulation. Ann Rev Neurosci 4: 419-461.
37. NAVARRO HA, KUDLACZ EM, KAVLOCK RJ, SLOTKIN TA, 1991a. Prenatal terbutaline treatment: tissue-selective dissociation of perinatal changes in β-adrenergic receptor binding from regulation of adenylate cyclase activity. Life Sci 48: 269-274.
38. NAVARRO HA, KUDLACZ EM, SLOTKIN TA, 1991b. Control of adenylate cyclase activity in developing rat heart and liver: effects of prenatal exposure to terbutaline or dexamethasone. Biol Neonate 60: 127-136.
39. PARASCHOS A, KARLINER JS, 1994. Receptor crosstalk: effects of prolonged carbachol exposure on β-adrenoceptors and adenylyl cyclase activity in neonatal rat ventricular myocytes. Naunyn-Schmiedebergs Arch Pharmacol 350: 267-276.
40. PING PP, GELZER-BELL R, ROTH DA, KIEL D, INSEL PA, HAMMOND HK, 1995. Reduced β-adrenergic receptor activation decreases G-protein expression and β-adrenergic receptor kinase activity in porcine heart. J Clin Invest 95: 1271-1280.
41. POINTON SE, BANERJEE SP, 1979. Alpha-and beta-adrenergic receptors of the rat salivary gland: elevation after chemical sympathectomy. Biochim Biophys Acta 584: 231-241.
42. PRACYK JB, SLOTKIN TA, 1991. Thyroid hormone differentially regulates development of β-adrenergic receptors, adenylate cyclase and ornithine decarboxylase in rat heart and kidney. J Dev Physiol 16: 251-261.
43. s in heterologous desensitization: a role for adenosine 3′, 5′-monophosphate-dependent phosphorylation. Endocrinology 131: 2774-2784.
44. ROBKIN MA, SHEPARD TH, DYER DC, 1976. Autonomic receptors of the early rat embryo heart: growth and development. Proc Soc Exp Biol Med 151: 799-803.
45. SÁNCHEZ-CAPELO A, PEÑAFIEL R, TOVAR A, GALINDO JD, CREMADES A, 1994. Postnatal development of ornithine decarboxylase and polyamines in the mouse kidney: influence of testosterone. Biol Neonate 66: 119-127.
46. SEAMON K, DALY JW, 1981. Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein. J Biol Chem 256: 9799-9801.
47. SEAMON KB, DALY JW, 1986. Forskolin: its biological and chemical properties. Adv. Cyclic Nucleotide Protein Phosphorylation Res 20: 1-150.
48. SEIDLER FJ, SLOTKIN TA, 1979. Presynaptic and postsynaptic contributions to ontogeny of sympathetic control of heart rate in the preweanling rat. Brit J Pharmacol 65: 431-434.
49. SHEAR M, INSEL PA, MELMON KL, COFFINO P, 1976. Agonist-specific refractoriness induced by isoproterenol. J Biol Chem 251: 7572-7576.
50. SLOTKIN TA, 1986. Endocrine control of synaptic development in the sympathetic nervous system: the cardiac-sympathetic axis. In: Gootman PM (ed.). Developmental Neurobiology of the Autonomic Nervous System. Clifton, NJ: Humana Press, 97-133.
51. SLOTKIN TA, LAPPI SE, SEIDLER FJ, 1995a. β-Adrenergic control of c-fos expression in fetal and neonatal rat tissues: relationship to cell differentiation and teratogenesis. Toxicol Appl Pharmacol 133: 188-195.
52. SLOTKIN TA, LAU C, MCCOOK EC, LAPPI SE, SEIDLER FJ, 1994a. Glucocorticoids enhance intracellular signaling via adenylate cyclase at three distinct loci in the fetus: a mechanism for heterologous teratogenic sensitization? Toxicol Appl Pharmacol 127: 64-75.
53. SLOTKIN TA, LAU C, SEIDLER FJ, 1994b. β-Adrenergic receptor overexpression in the fetal rat: distribution, receptor subtypes and coupling to adenylate cyclase via G-proteins. Toxicol Appl Pharmacol 129: 223-234.
54. SLOTKIN TA, LORBER BA, MCCOOK EC, BARNES GA, SEIDLER FJ, 1995b. Neural input and the development of adrenergic intracellular signaling: neonatal denervation evokes neither receptor upregulation nor persistent supersensitivity of adenylate cyclase. Dev Brain Res 88: 17-29.
55. SLOTKIN TA, MCCOOK EC, SEIDLER FJ, 1993. Glucocorticoids regulate the development of intracellular signaling: enhanced forebrain adenylate cyclase catalytic subunit activity after fetal dexamethasone exposure. Brain Res Bull 32: 359-364.
56. SLOTKIN TA, NAVARRO HA, MCCOOK EC, SEIDLER FJ, 1990. Fetal nicotine exposure produces postnatal up-regulation of adenylate cyclase activity in peripheral tissues. Life Sci 47: 1561-1567.
57. STEIN HM, OYAMA K, SAPIEN R, CHAPPELL BA, PADBURY JF, 1992. Prolonged β-agonist infusion does not induce desensitization or down-regulation of β-adrenergic receptors in newborn sheep. Pediatr Res 31: 462-467.
58. STILES GL, 1989. Mechanisms of receptor activation in adenylate cyclase. J Cardiovasc Pharmacol 14: S1-S5.
59. THAI L, GALLUZZO JM, MCCOOK EC, SEIDLER FJ, SLOTKIN TA, 1996. Atypical regulation of hepatic adenylyl cyclase and adrenergic receptors during a critical developmental period: agonists evoke supersensitivity accompanied by failure of receptor downregulation. Pediatr Res 39: 697-707.
60. WAGNER JP, SEIDLER FJ, LAPPI SE, MCCOOK EC, SLOTKIN TA, 1994. Role of thyroid status in the ontogeny of adrenergic cell signaling in rat brain: beta receptors, adenylate cyclase, ornithine decarboxylase and c-fos protooncogene expression. J Pharmacol Exp Ther 271: 472-483.
61. WAGNER JP, SEIDLER FJ, LAPPI SE, MCCOOK EC, SLOTKIN TA, 1995. Role of presynaptic input in the ontogeny of adrenergic cell signaling in rat brain: beta receptors, adenylate cyclase, and c-fos protooncogene expression. J Pharmacol Exp Ther 273: 415-426.
62. WAGNER JP, SEIDLER FJ, SLOTKIN TA, 1991. Presynaptic input regulates development of β-adrenergic control of rat brain ornithine decarboxylase: effects of 6-hydroxydopamine or propranolol. Brain Res Bull 26: 885-890.
63. WEISS ER, KELLEHER DJ, WOON CW, SOPARKAR S, OSAWA S, HEASLEY LE, JOHNSON GL, 1988. Receptor activation of G proteins. FASEB J 2: 2841-2848.
64. WHITAKER-AZMITIA PM, 1991. Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology. Pharmacol Rev 43: 553-561.
65. YAMADA S, YAMAMURA HI, ROESKE WR, 1980. Alterations in cardiac autonomic receptors following 6-hydroxydopamine. Mol Pharmacol 18: 185-192.
66. YAMADA S, YAMAMURA HI, ROESKE WR, 1986. Effects of chemical sympathectomy with 6-hydoxydopamine on α-and β-adrenoceptors and muscarinic cholinoceptors in rat kidney. Eur J Pharmacol 121: 345-353.
67. s-catalytic unit complex of adenylate cyclase in isoproterenol-induced heterologous desensitization. Eur J Pharmacol 159: 247-256.